A sequence of cellular and molecular events involved in IL12-induced tumour regression.
Fujiwara
H
H
Osaka University Medical School, Japan.
Zou
J P
JP
Herrmann
S
S
Hamaoka
T
T
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002455:Cell Division / Q000187:drug effects / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular; D018664:Interleukin-12 / Q000627:therapeutic use*; D009374:Neoplasms, Experimental / Q000276:immunology* / Q000473:pathology / Q000628:therapy*
D000970:Antineoplastic Agents; D018664:Interleukin-12